Company: THC
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001193125-25-079143
Chunk: 81

Company: TENET HEALTHCARE CORP
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 81
---
 2025 Annual Meeting of Shareholders.” This resolution, commonly referred to as a “say-on-pay”resolution, will be considered to have been approved by shareholders on an advisory basis if the votes cast for approval exceed the votes cast against approval. This advisory resolution is not binding on the Board. Although non-binding,the Board and the HR Committee will review and consider the voting results when making future decisions regarding our executive compensation program. Unless the Board modifies its policy of holding an advisory say-on-payvote on an annual basis, the next advisory say-on-payvote will be held at our 2026 Annual Meeting of Shareholders.

| The Board recommends that you vote “FOR” the approval of the advisory resolution to approve executive compensation. |

| 80 |

Audit Committee Report The Audit Committee is composed of the members named below, each of whom is independent, as defined by the NYSE rules and the rules of the SEC. The Board has determined that Mr. Fisher, Mr. Lynch and Ms. Romo are each an Audit Committee Financial Expert, as defined by SEC rules, and that each Audit Committee member is financially literate, as required by NYSE rules. The Audit Committee has reviewed and discussed with management and the Company’s independent registered public accountants, Deloitte & Touche LLP (Deloitte), the audited consolidated financial statements for the year ended December 31, 2024. The Audit Committee has discussed with Deloitte the matters required to be discussed under applicable professional auditing standards and regulations adopted by the Public Company Accounting Oversight Board (PCAOB) and the SEC. In addition, the Audit Committee received and reviewed the written disclosures and the letter from Deloitte required by applicable requirements of the PCAOB regarding Deloitte’s communications with the Audit Committee concerning independence and has discussed with Deloitte its independence from management and the Company. In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board that the Company’s 2024 audited consolidated financial statements be included in the Form 10-Kand filed with the SEC. Members of the Audit Committee Tammy Romo, Chair Roy Blunt Richard W. Fisher Cecil D. Haney Christopher S. Lynch Richard J. Mark

| 2025 PROXY STATEMENT |     | 81 |

Independent Registered Public Accounting Firm Fees

|                       |     |     |        Year Ended 
 December 31, 2024 |     |     |        Year Ended 
 December 31, 2023 |
|:----------------